| Prev Close: | 9.23 |
|---|---|
| Open: | 9.20 |
| Bid: | 9.14 x 900 |
| Ask: | 9.22 x 25000 |
| 1y Target Est: | 8.37 |
| Beta: | 1.24 |
| Next Earnings Date: | 24-Jul-13 |
| Day's Range: | 9.10 - 9.34 |
|---|---|
| 52wk Range: | 4.79 - 9.39 |
| Volume: | 32,703,692 |
| Avg Vol (3m): | 18,694,700 |
| Market Cap: | 12.33B |
| P/E (ttm): | N/A |
| EPS (ttm): | -3.28 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BSX Entangled in Patent IssuesZacks(Wed 2:15PM EDT)
- InPlay: Boston Scientific: New data demonstrate significant and sustained blood pressure reduction with Boston Scientific Vessix Renal Denervation SystemBriefing.com(Wed 12:23PM EDT)
- New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation SystemPR Newswire(Wed 12:20PM EDT)
- Medtronic Still Reporting Weak Growth, But A Relatively Rare Bargainat Investopedia(Wed 11:35AM EDT)
- Boston Scientific’s Lotus Aortic Valve Shows Promise in Studyat Bloomberg(Wed 10:50AM EDT)
- Boston Scientific says Lotus system met primary performance endpoint in trialtheflyonthewall.com(Wed 10:44AM EDT)
- Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II TrialPR Newswire(Wed 10:40AM EDT)
- Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy DataPR Newswire(Wed 9:12AM EDT)
- Medtronic Beats Earnings, Results StrongerZacks(Wed 9:10AM EDT)
- 4 Healthcare Stock Stories For Tuesday Investment Wellnessat Wall St. Cheat Sheet(Tue, May 21)
- What's Behind Medtronic's 5% Pop?at Motley Fool(Tue, May 21)
- Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients with Severe AsthmaPR Newswire(Tue, May 21)
- American Society Of Clinical Oncology Abstracts Point To Potential Profitsat Seeking Alpha(Tue, May 21)
- Insiders Are Buying These Stocks Nowat Motley Fool(Tue, May 21)
- Medtronic’s Heart Rhythm Devices Show Signs of Growthat Bloomberg(Tue, May 21)
Press Releases
- New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation SystemPR Newswire(Wed 12:20PM EDT)
- Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II TrialPR Newswire(Wed 10:40AM EDT)
- Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy DataPR Newswire(Wed 9:12AM EDT)
Reports
- BSX: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 22)
- Thomson Reuters Stock Report - BOSTON SCIENTIFIC CORPORATION (BSX-N)Thomson Reuters Stock Report(May 22)
- ValuEngine Industry Report for Medical ProductsValuEngine, Inc.(May 22)